UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 387

Sortiert nach

An Exploration of Small Molecules That Bind Human Single-Stranded DNA Binding Protein 1

Biology (Basel, Switzerland), 2023-11, Vol.12 (11), p.1405

2023

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer stem cells: The root of resistance

Cancer letters, 2016-03, Vol.372 (2), p.147-156

2016

Link zum Volltext

Verfügbarkeit prüfen

Macrophage and Mast-Cell Invasion of Tumor Cell Islets Confers a Marked Survival Advantage in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-12, Vol.23 (35), p.8959-8967

2005

Link zum Volltext

Verfügbarkeit prüfen

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells

Cancers, 2019-04, Vol.11 (4), p.548

2019

Link zum Volltext

Verfügbarkeit prüfen

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi

Frontiers in oncology, 2018-03, Vol.8, p.92-92

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2780-2787

2014

Link zum Volltext

Verfügbarkeit prüfen

The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer

Frontiers in oncology, 2020-07, Vol.10, p.1256-1256

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer

The European respiratory journal, 2015-12, Vol.46 (6), p.1762-1772

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group

Journal of clinical oncology, 2005-07, Vol.23 (19), p.4265-4274

2005

Link zum Volltext

Verfügbarkeit prüfen

Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines

Scientific reports, 2018-01, Vol.8 (1), p.1652-12, Article 1652

2018

Link zum Volltext

Verfügbarkeit prüfen

Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer

Molecular cancer, 2011-03, Vol.10 (1), p.25-25, Article 25

2011

Link zum Volltext

Verfügbarkeit prüfen

Structural investigation of CDCA3‐Cdh1 protein–protein interactions using in vitro studies and molecular dynamics simulation

Protein science, 2023-03, Vol.32 (3), p.e4572-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

A structural analysis of DNA binding by hSSB1 (NABP2/OBFC2B) in solution

Nucleic acids research, 2016-09, Vol.44 (16), p.7963

2016

Link zum Volltext

Verfügbarkeit prüfen

Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture

Assay and drug development technologies, 2016-02, Vol.14 (1), p.19

2016

Link zum Volltext

Verfügbarkeit prüfen

Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer

PloS one, 2011-01, Vol.6 (1), p.e14593-e14593

2011

Link zum Volltext

Verfügbarkeit prüfen

First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study

The lancet oncology, 2011, Vol.12 (1), p.30-37

2011

Link zum Volltext

Verfügbarkeit prüfen

IL - 20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF

European journal of cancer (1990), 2011-08, Vol.47 (12), p.1908-1918

2011

Link zum Volltext

Verfügbarkeit prüfen

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6

British journal of cancer, 2017-01, Vol.116 (2), p.175-185

2017

Link zum Volltext

Verfügbarkeit prüfen

A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE

Nature communications, 2024-02, Vol.15 (1), p.1823-1823

2024

Link zum Volltext

Verfügbarkeit prüfen

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer

Molecular cancer, 2015-02, Vol.14 (1), p.45-45, Article 45

2015

Link zum Volltext

Verfügbarkeit prüfen

Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM)

PloS one, 2013-08, Vol.8 (8), p.e70940-e70940

2013

Link zum Volltext

Verfügbarkeit prüfen

KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma

International journal of oncology, 2016-03, Vol.48 (3), p.1290-1296

2016

Link zum Volltext

Verfügbarkeit prüfen

26 – 50 von 387

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(361)
Mit Volltextzugriff
(372)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(230)
Life Sciences & Biomedicine
(215)
Humans
(194)
Oncology
(154)
Female
(86)
Male
(82)
Middle Aged
(76)
Aged
(71)
Adult
(69)
Lung Cancer
(67)
Lung Neoplasms - Pathology
(57)
Biological And Medical Sciences
(56)
Lung Neoplasms - Drug Therapy
(54)
Chemotherapy
(53)
Medical Sciences
(53)
Tumors
(50)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(44)
Lung Neoplasms - Genetics
(43)
Respiratory System
(41)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

An Exploration of Small Molecules That Bind Human Single-Stranded DNA Binding Protein 1

Lung cancer stem cells: The root of resistance

Macrophage and Mast-Cell Invasion of Tumor Cell Islets Confers a Marked Survival Advantage in Non–Small-Cell Lung Cancer

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project

Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1

The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer

Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817

Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group

Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines

Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer

Structural investigation of CDCA3‐Cdh1 protein–protein interactions using in vitro studies and molecular dynamics simulation

A structural analysis of DNA binding by hSSB1 (NABP2/OBFC2B) in solution

Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture

Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer

Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer

First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study

IL - 20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6

A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer

Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM)

KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma

Suchergebnisse filtern